We speculated that sivelestat sodium, as a selective neutrophil elastase inhibitor, cannot suppress the metastasis of lung cancer, in contrast to the multi-targeting natural product EGCG, via the PI3K/Akt signaling pathway. This evidence concerns the gene AKT1 and lung carcinoma.